AKERO THERAPEUTICS IN
23.50
25-6月-24 15:59:58
15 分の遅延
株式
-0.35
-1.47%
本日の幅
23.31 - 23.99
ISIN
N/A
ソース
NASDAQ
-
19 9 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
14 9 2022 20:07:00 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics Announces Proposed Public Offering of Common Stock
13 9 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
08 9 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
24 8 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
04 8 2022 16:05:37 提供 Nasdaq GlobeNewswire
-
16 6 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics to Present at Keystone Symposium on Efruxifermin as a Therapy for NASH
13 6 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics to Present at the Jefferies Global Healthcare Conference
01 6 2022 16:05:00 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics Reports First Quarter 2022 Financial Results
06 5 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics to Present at Upcoming Healthcare Conferences in May
02 5 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
25 2 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics Completes Enrollment of Phase 2b HARMONY Study in Pre-Cirrhotic NASH Patients
08 2 2022 08:00:03 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
04 1 2022 16:05:00 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics to Present at the Evercore ISI 4th Annual HealthCONx Virtual Conference
26 11 2021 17:28:49 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update
12 11 2021 07:00:02 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics to Present at the Jefferies London Healthcare Conference
09 11 2021 16:15:00 提供 Nasdaq GlobeNewswire